ziprasidone
Health Canada Approves Ziprasidone Hydrochloride for Bipolar Disorder
Thursday, February 12th, 2009Health Canada has approved ziprasidone hydrochloride (Geodon/Zeldox) for the treatment of acute manic or mixed episodes associated with bipolar disorder.
“As many bipolar disorder medications cause substantial weight gain, it is often challenging to treat patients for this serious and often disabling condition,” said Roger McIntyre, MD, Mood Disorders Psychopharmacology Unit, University Health Network, and University [...]
